论文部分内容阅读
将６０ 例缺血性脑血管病患者随机分成两组，各给予东菱精纯克栓酶共２０ＢＵ ，隔日给药组３０ 例，发病第１ 、３ 、５ 天给药；连续给药组３０ 例，发病第１ 、、２ 、３ 天给药。结果连续给药组总有效率为９３ ．３ ％ ，隔日给药组总有效率为８６ ．７ ％ ，两组总有效率差异无显著性（ Ｐ ＞ ０ ．０５） 。两组治疗后神经功能缺损评分减少差异有高度显著性（ Ｐ ＜ ０ ．０１） 。认为两组给药方法均能起到较好治疗作用，不同的给药方法可出现疗效差异
60 patients with ischemic cerebrovascular disease were randomly divided into two groups, each given Dongling Jing Ke acanthopanax a total of 20BU, 30 cases every other day, the incidence of 1, 3, 5 days administration; continuous administration 30 For example, the incidence of the first 1, 2, 3 days administration. The results of continuous administration group total efficiency of 93. 3%, the next day the total effective rate of 86 groups. 7%, there was no significant difference between the two groups (P> 0.05). There was a significant difference between the two groups in the reduction of neurological deficit score (P <0.01). It is considered that both methods of administration can play a better therapeutic effect, and different administration methods may have different therapeutic effects